Insights

Preservative Free Horus Pharma prioritizes preservative-free formulations and delivery systems, creating a potential sales angle to supply compatible packaging, devices, and alternative excipients for preservative-free ophthalmic products.

Strategic Partnerships Recent collaborations with Formycon for a biosimilar and long-standing distribution ties (e.g., ILUVIEN) indicate openness to co-market and expand portfolio in Europe, signaling channel partnerships and co-promotional opportunities.

Surgery Focus The newly established Surgery Division offers peri-surgical eye disease solutions, presenting upsell opportunities for surgical devices, diagnostic tools, and support services to ophthalmic clinics and hospitals.

Sustainability Link Environmental initiatives with Plastic Bank and a preservative-free culture can be leveraged to position products and packaging that appeal to sustainable procurement programs in health systems.

Growth Footprint With a growing European footprint, strategic prospects exist in expanding sales of existing products, exploring new markets for biosimilars, and leveraging the company’s R&D emphasis to partner on innovative ophthalmic solutions.

Similar companies to Horus Pharma

Horus Pharma Tech Stack

Horus Pharma uses 8 technology products and services including SAP SuccessFactors, Power BI, Qlik, and more. Explore Horus Pharma's tech stack below.

Media & News

Horus Pharma's Email Address Formats

Horus Pharma uses at least 4 email formats:
Horus Pharma Email FormatsExamplePercentage
First.Last@horus-pharma.comJohn.Doe@horus-pharma.com
93%
First.MiddleLast@horus-pharma.comJohn.MichaelDoe@horus-pharma.com
4%
Last@horus-pharma.comDoe@horus-pharma.com
2%
First.Middle@horus-pharma.comJohn.Michael@horus-pharma.com
1%

Frequently Asked Questions

What is Horus Pharma's phone number?

Minus sign iconPlus sign icon
You can contact Horus Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Horus Pharma's official website and social media links?

Minus sign iconPlus sign icon
Horus Pharma's official website is horus-pharma.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Horus Pharma generate?

Minus sign iconPlus sign icon
As of October 2026, Horus Pharma's annual revenue is estimated to be $1M - $10M.

What is Horus Pharma's NAICS code?

Minus sign iconPlus sign icon
Horus Pharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Horus Pharma have currently?

Minus sign iconPlus sign icon
As of October 2026, Horus Pharma has approximately 279 employees across 4 continents, including Europe, Africa and North America. Key team members include Head Of Information Systems: M. S., Présidente: M. C. and Group Cfo: V. V. Explore Horus Pharma's employee directory with LeadIQ.

What industry does Horus Pharma belong to?

Minus sign iconPlus sign icon
Horus Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does Horus Pharma use?

Minus sign iconPlus sign icon
Horus Pharma's tech stack includes SAP SuccessFactors, Power BI, Qlik, Microsoft SharePoint, WordPress, Microsoft 365, DocuSign and Microsoft Azure.

What is Horus Pharma's email format?

Minus sign iconPlus sign icon
Horus Pharma's email format typically follows the pattern of First.Last@horus-pharma.com. Find more Horus Pharma email formats with LeadIQ.

How much funding has Horus Pharma raised to date?

Minus sign iconPlus sign icon
As of October 2026, Horus Pharma has raised $25M in funding. The last funding round occurred on Mar 14, 2022 for $25M.

When was Horus Pharma founded?

Minus sign iconPlus sign icon
Horus Pharma was founded in 2003.
Horus Pharma logo

Horus Pharma

Pharmaceutical ManufacturingProvence-Alpes-Côte d'Azur, France201-500 Employees

Horus Pharma is a French pharmaceutical manufacturer focused on eye and eyelid health, developing, patenting and marketing products for ophthalmology. The company emphasizes patient safety through preservative-free formulations and delivery systems, aiming to maintain microbiological quality without preservatives. Its portfolio includes medicinal products, medical devices and dietary supplements, and it has created a Surgery Division to offer surgical and peri-surgical solutions that aid in diagnosing eye diseases.
Based in Nice, in the Provence-Alpes-Côte d'Azur region, Horus Pharma was founded in 2003 and operates in the ophthalmology space across Europe. In 2025 the company announced a strategic collaboration to semi-exclusively commercialize Formycon's Eylea biosimilar FYB203 under the Baiama brand in selected European markets.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2003
Employees
201-500

Section iconFunding & Financials

  • $25M

    Horus Pharma has raised a total of $25M of funding over 2 rounds. Their latest funding round was raised on Mar 14, 2022 in the amount of $25M as a Venture Round.

  • $1M - $10M

    Horus Pharma's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.